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ABBREVIATIONS:
AF: Arterial Flow;  
CLM: Colorectal Liver Metastases; 
DCE-CT: Dynamic Contrast-Enhanced 
imaging with Computed Tomography; 
MVD: Micro Vessel Density; 
PF: Portal Flow; 
PI: Perfusion Index; 
RECIST: Response Evaluation Criteria in Solid 
Tumours; 
uPAR: urokinase Plasminogen Activator 
Receptor; 
2D ROI: two-dimensional Region of Interest; 
3D VOI: three-dimensional Volume of Interest.
Introduction
Advanced colorectal cancer shows a poor 
prognosis, and more than 50% of patients 
develop metastases, most frequently in 
the liver, during their disease course [1,2]. 
Angiogenesis, which is important in the growth 
and metastasis of carcinomas, appears to be 
a promising prognostic marker for colorectal 
cancer and microvessel density count is used 
to define the number of angiogenic blood 
vessels in tumours, where the vessel density is 
quantified by microscopy or digital pathology 
[3-5]. Studies have shown that the microvessel 
density can be used as a predictor of prognosis in 
colorectal liver metastases [4,6], and in a study 
by Eefsen et al. [5] the results showed a lower 
level of microvessel density in patients with 
colorectal liver metastases who were treated with 
chemotherapy.
The urokinase plasminogen activator receptor 
(uPAR) is a protein of the plasminogen family, 
which is up regulated in several tumours [7-9] 
and seems to play a role in angiogenesis [10-13]. 
Assessment of the correlation 
between dynamic contrast enhanced 
computed tomography and 
histological and vascular biomarkers 
in patients resected for colorectal liver 
metastases
Background: Dynamic contrast-enhanced computed tomography (DCE-CT) is a promising non-
invasive method that provides the functional evaluation of the vascularity in normal and malignant 
tissue.
The objectives of this consecutive study were to investigate the possible correlation between the 
perfusion characteristics of colorectal cancer liver metastases as examined by (DCE-CT) and the 
microvessel density of resected metastases. An additional aim was to investigate the correlation 
between the urokinase plasminogen activation receptor (uPAR) and perfusion values.
Methods and findings: Eleven patients fulfilled the criteria for comparative analyses. The 
microvessel density values, uPAR level and the DCE-CT values were analysed. A perfusion index 
(PI) based on the measurement of arterial and portal flow (AF, PF) was defined as follows: PI=AF/ 
(AF+PF)%. The DCE-CT measurements were compared between metastatic and normal liver tissues. 
A Spearman correlation test was used for statistical analysis.
The perfusion index and microvessel density values were significantly correlated (r=0.75; p=0.01). 
Furthermore, a higher volume of metastases significantly correlated with higher plasma levels of 
the uPAR forms (0.72 ≤ r ≥ 0.89; p<0.05).
Conclusions: DCE-CT may have the potential to measure the vascularity of colorectal liver 
metastases; however, the correlation between microvessel density and the perfusion values 
appears vague. 
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Conventional CT scans are currently the 
most commonly used imaging modality for 
monitoring malignant tissue using the RECIST 
criteria (response evaluation criteria in solid 
tumours) [14]. However, dynamic contrast-
enhanced - CT is a relatively new technology 
that allows measurement of tumour vascularity 
and the method can easily be integrated into 
routine CT imaging protocols, within the same 
session [15]. Thus, DCE-CT may provide 
qualitative and quantitative information 
on perfusion patterns in metastatic tumour 
tissue, with the potential to serve as a tool for 
monitoring therapy-induced changes in various 
types of lesions [13]. 
Two studies showed a significant correlation 
between DCE-CT and microvessel density 
values in patients with colorectal liver metastases 
[16,17]. Studies evaluating the correlation 
between the DCE-CT values and the plasma 
uPAR forms have not yet been described but 
two studies have shown that a high urokinase 
plasminogen activator receptor correlates to a 
poor prognosis [18,19].
Therefore, the aim of this study was to 
investigate the possible correlation between 
DCE-CT and microvessel density in patients 
with colorectal liver metastases as well as the 
possible correlation between different uPAR 
forms in the plasma and DCE-CT values.
Methods
  Patients
Twenty-eight consecutive patients with 
histologically confirmed colorectal liver 
metastases, who had not received chemotherapy 
before surgical liver resection, were invited to 
participate in this study after written informed 
consent was obtained. The inclusion criteria 
were as follows: (I) patients with histologically 
confirmed metastatic colorectal cancer; II) 
patients aged 18 y or older; (III) patients with 
at least one metastasis larger than 1 cm; (IV) 
patients who agreed to take part in this study 
after informed consent; and (V) patients with 
no renal dysfunction and allergy to the contrast 
material. Nineteen patients fulfilled these criteria 
and were scanned (the day before surgery) from 
August 2013 to December 2014. Eight patients 
were excluded due to no detectable metastases 
at the DCE-CT examination (the metastases 
were smaller than 1 cm but were seen on 
conventional CT images and by the surgeons), 
resulting in 11 patients (two women and nine 
men; mean age, 69 y; range, 46-84 y) were 
included for the analyses of DCE-CT values, 
uPAR and microvessel density (FIGURE 1). 
This study was approved by the Committees of 
Health Research Ethics in the Capital Region 
of Denmark ((H-1-2013-027) and the Danish 
Data Protection Agency (2007-58-0015).
  DCE-CT - technique
All of the examinations were performed using 
a 320-detector row CT scanner (Aquilion One, 
Toshiba Medical Systems, Otawara, Japan), 
which enabled rapid volumetric acquisitions 
over a range of 16 cm. This approach range made 
it possible to cover almost the entire liver with a 
Figure 1. Study flow diagram showing the enrolment in the study.
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single gantry rotation. A pump injector (Medrad 
Stellant © Bayer Healthcare, Leverkusen, 
Germany) was used to inject 50 mL of intravenous 
nonionic contrast medium (Omnipaque 350 © 
GE Healthcare, Milwaukee, WI, USA) and 50 
mL saline through an 18-gauge catheter at a 
rate of 6 mL/s placed in an ante-cubital vein. 
The following CT parameters were used: 100 
kV; 110 mA; 0.275 s gantry rotation time; 0.5 
mm reconstructed slice thickness; matrix 512 × 
512; and a volume scan image reconstruction 
with an adaptive iterative dose reduction 3D 
(AIDR 3D-standard) algorithm. The DCE-CT 
protocol consisted of 19 consecutive volumes 
divided into three sequences. The first sequence 
included nine volumes with an interval of two 
s, the second sequence contained six volumes 
with an interval of 3 s, and the third sequence 
encompassed four volumes with an interval of 
five seconds.
The initial delay of the first sequence started 
13 s after the contrast administration, and the 
total DCE-CT scanning time was 72 s. During 
the acquisition, an abdominal strap was placed 
around the abdomen of the patients to restrict 
the abdominal wall excursion, and the patients 
were also asked to breathe shallow to minimize 
the respiratory motion of the liver. The total 
dose-length product (DLP) of 19 volumes was 
1,006.4 mGy* cm, which was equivalent to an 
effective dose of 15.1 mSv (k=0,015).
  Image analysis - DCE-CT
Automated motion registration was applied 
using a non-rigid deformable registration 
technique for anatomic alignment of multiple 
scans using software (Body Registration ©; 
Toshiba Medical Systems, Otawara, Japan) 
[20,21]. Subsequently, the reconstructed, 
motion corrected datasets were transferred to 
a stand-alone workstation (Vitrea 6.3 ©, Vital 
Images, Toshiba Medical Systems, Otawara, 
Japan) for the DCE-CT analysis. Peak vascular 
enhancement was measured from a circular ROI 
within the abdominal aorta at the level of the 
hepatic hilus, a second ROI within the portal 
vein, a third ROI within the normal tissue of the 
liver, and a fourth ROI within the spleen.
Regarding the ROI in the normal liver 
parenchyma, care was taken to exclude the 
large hepatic vessels and to include as much 
of the normal liver parenchyma as possible in 
at least 2 cm from the metastases. The time for 
the maximum enhancement of the spleen was 
used to separate the arterial and portal venous 
phases of hepatic enhancement [22]. The DCE-
CT values were then calculated using the dual 
input, maximum slope model encompassing 
measurements of the hepatic arterial flow (AF) 
(mL/min/100 g), portal venous perfusion (PF) 
(mL/min/100 g) and perfusion index (PI=AF/
(AF+PF)%) of the metastases. The DCE-CT 
values were measured for each metastasis, but for 
patients who had more than one liver metastasis, 
only the largest was used for the analysis. 
Freehand-drawn 2D ROIs (range 10-100 
mm2) were placed at the tumour edge (12-3-6-9 
o`clock positions), and care was taken to ensure 
that the ROIs were close to the tumour border 
but still within the tumour boundaries. The 
perfusion values in the metastases were calculated 
as the mean values for all the clock positions 
(FIGURE 2). For measuring the perfusion 
values in normal tissue, 2D ROIs of 600 mm2 
were placed in three images with a distance of 3 
mm. Furthermore, a 3D VOI, encompassing the 
entire volume of the metastases was established, 
as shown in FIGURE 3. We decided to compare 
the 2D ROIs in metastases with the 2D ROIs 
in the normal liver parenchyma, because it was 
not possible to avoid the vessels and malignant 
tissue using the 3D measurement in normal 
tissue. All the ROI and VOI measurements were 
performed by a trained observer. 
  Histopathologic and image analysis - 
Microvessel density
At the time of liver surgery, the removed 
metastases were marked in three dimensions, 
including the cranio-rostral, right-left and 
antero-posterior dimensions. The cranial part of 
the tissue was marked with a long thread, the 
right side was marked with a short thread, and 
the anterior part was marked with two short 
threads. In this way, it was possible to orient 
the metastasis according to the position in the 
liver, making it possible to perform histological 
analyses from the areas examined by DCE-CT. 
The tissue from the resected liver metastases 
was formalin-fixed and paraffin-embedded, 
and then 3 μm sections were cut. The sections 
were deparaffinized and rehydrated by a 
xylene- ethanol series. Afterwards, antibodies 
against CD31 and Ki67 were added for double 
immunostaining using the Envision G2 
Doublestain System Kit (K5361, Dako) [5]. 
Imaging Med. (2018) 10(6) 149
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The monoclonal antibody against Ki67 (clone 
MIB-1, Dako) was diluted to 0.92 μg/mL 
and was added first. The signal was developed 
with a diaminobenzidine chromogen. The 
second primary antibody against CD31 (clone 
JC70A, Dako) was diluted to 1.03 μg/mL and 
was visualized with Permanent Red. The slides 
were scanned in a Hamamatsu slide scanner 
(NanoZoomer 2.0-HT, Hamamatsu City, 
Japan) and were imported in the VisiomorphDP 
(Visiopharm, Hørsholm, Denmark) in order to 
be analysed using a vessel app [5]. Five ROIs 
were drawn at the tumour periphery of every 
tissue slide, and the microvessel density value for 
each metastasis was an average of the micro vessel 
density values within five squares. Each square 
was 250 μm*250 μm=62.500 μm2=0.0625 
mm2. If more than one metastasis was resected, 
the analysis was performed on the largest 
metastasis. The size of the histological analysed 
area was 5 × 0.0625 mm2 = 0.31 mm2, and the 
maximum size of the 2D ROIs from the DCE-
CT scans was 100 mm2. Thus, the area of a ROI 
applied in the perfusion CT was approximately 
300 times larger than the histological ‘window’. 
  Quantification of the uPAR forms
Blood samples were collected pre-operatively 
in 9 mL EDTA-coated tubes (Vacutainer Becton- 
Dickinson, Mountain View, CA, USA). Within 
30 min, the tubes were centrifuged at 2,200 G 
for 10 min at 20-24ºC. The plasma samples 
Figure 2. DCE-CT scans of a 74-year-old female patient with colorectal liver metastases. The perfusion 
values were measured by the 2D ROI method. The red circles represent the 2D ROIs in the metastasis.
Figure 3. DCE-CT scan of a 78-year-old female patient with colorectal liver metastases. The perfusion 
values were measured by the 3D VOI method, encompassing the entire volume of the metastases (displayed 
by the red area).
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were frozen within an hour after centrifugation 
and were stored at -80ºC until the analysis. 
Three different time-resolved fluorescence 
immunoassays (TR- FIAs) were used to measure 
the different uPAR forms in EDTA plasma, 
including TR-FIA 1 measuring intact uPAR 
(domains I-III), TR-FIA 2 measuring uPAR 
(domains I-III) + uPAR (domains II-III) [23] 
and TR-FIA 4 measuring the liberated domain 
I of uPAR (domain I). All three assays were 
validated for use in 20% EDTA plasma [18]. All 
the samples were measured in duplicate, and the 
mean values were used for the statistical analyses.
  Statistical analysis
Nonparametric methods were used for the 
analysis, and all correlations were assessed using 
Spearman correlation coefficients. A two-tailed 
Wilcoxon rank sum test was used to test the 
observed differences in perfusion values between 
the metastases and normal tissue. A p-value less 
than 0.05 was considered statistically significant. 
This study was an explorative study where no 
previous results were available to perform a 
power calculation. 
Results
DCE-CT values, microvessel density and 
uPAR were evaluated in 11 patients (two 
women and nine men; mean age, 69 y; range, 
46-84 y) diagnosed with histologically proven 
colorectal liver metastases. TABLE 1 shows the 
mean DCE-CT values, histological parameters, 
and the mean plasma levels of the uPAR forms.
  Microvessel density and DCE-CT
A statistically significant correlation was 
observed between the perfusion index value at 
the tumour periphery, as measured by 2D ROIs, 
and the microvessel density (r=0.75, p=0.01) 
as shown in TABLE 2. There were no other 
significant correlations between the microvessel 
density score and the other perfusion values.
  uPAR forms and DCE-CT
None of the perfusion values (PI, AF, PF) 
measured by 3D VOIs were significantly 
correlated to any of the uPAR forms (Spearman 
Rank correlation coefficient (range: -0.61 ≤ r ≤ 
-0.01; p>0.98) as shown in TABLE 3. However, 
there was a statistically significant correlation 
(range: 0.72 ≤ r ≤ 0.89; p<0.0002) between 
all the uPAR forms and the volumes of the 
metastases measured by 3D VOIs (TABLE 4). 
  DCE-CT values in malignant tissue and 
normal liver parenchyma
The mean perfusion index value of the liver 
metastases (31.37%) was significantly higher 
than for the surrounding normal liver tissue 
Table 1. The numerical data for the DCE-CT parameters, histologic and plasma values.
Parameter Metastases (3D VOIs)
(Mean ( ± SD)
Metastases (2D ROIs)
(Mean ) ( ± SD)
Perfusion Index (%) 31.37 (7.9) 35.05 (5.3)
Perfusion Index (%) 31.37 (7.9) 35.05 (5.3)
Arteriel Flow (mL/min/100 g) 47.75 (13.5) 54.95 (11.4)
Portal Flow (mL/min/100 g) 120.50 (42.7) 103.95 (39.6)
Volume (cm3) 29.68 (74.7)
MVD 0.031 (0.02)
uPAR TR-FIA1 36.91 (10.7)
uPAR TR-FIA2 82.23 (24.1)
uPAR TR-FIA4 33.00 (11.4)
Table 2. Spearman rank correlation coefficient and p-values of the DCE-CT values (2D ROIs) 
and microvessel Density.
Histology DCE-CT
(2D ROIs)
Perfusion Index (%) Arteriel Flow (mL/min/100 g) Portal Flow (mL/min/100 g)
r p r P r p
Mean MVD (n=11) 0.751 0.011 0.381 0.251 -0.121 0.731
1the measurements are a mean value for all the "clock positions".
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(19.08%) (p=0.002) respectively. No significant 
difference was observed between the AF in 
the normal liver parenchyma and in the liver 
metastases. However, the PF in the normal 
liver tissue was significantly higher than that in 
liver metastases, p=0.001. The perfusion values 
for all 19 patients who received DCE-CT of 
the normal liver parenchyma are shown in the 
TABLE 5.1 and 5.2.
Discussion
In the present study, we examined the possible 
correlation among perfusion values and the 
microvessel density as well as between DCE-CT 
and the uPAR forms in plasma. Out of the three 
perfusion-values, we only found a statistically 
significant correlation between the perfusion 
index and the microvessel density values. 
The correlation between microvessel density 
and perfusion values, however, has been 
observed in two studies by Dighe et al. [6] and 
Sun et al. [24]. These studies included patients 
with primary colorectal cancer, all patients 
were examined with DCE-CT and the results 
showed no significant correlation between 
microvessel density and DCE-CT values of the 
primary tumour. However, the two mentioned 
studies differed from our study since the 
surgeons did not mark the metastases, making 
it more difficult to correlate the DCE-CT and 
histological findings. 
Furthermore, they used other protocols 
for performing the DCE-CT exams as well 
as different kinetic models for analysing the 
perfusion values.
In our study, we did not detect any significant 
correlation between the DCE-CT perfusion 
Table 3. Spearman rank correlation coefficient and p-values of the DCE-CT values (3D VOIs) 
and uPAR forms.
Plasma 
DCE-CT
(3D ROIs)
Perfusion Index (%) Arteriel Flow (mL/min/100 g) Portal Flow (mL/min/100 g)
r p r p r p
uPAR TR-FIA1
(n=11) -0.01 0.98 -0.19 0.58 -0.37 0.26
uPAR TR-FIA2
(n=11) 0.08 0.78 -0.43 0.19 -0.61 0.05
uPAR TR-FIA4
(n=11) -0.08 0.81 -0.21 0.54 -0.44 0.18
Table 4. Spearman rank correlation coefficient and p-values of the volume (cm3) of 
metastases (3D VOIs) and uPAR forms.
Histology
DCE-CT
(Volumes measured in cm3)
r p
uPAR TR-FIA1
(n=11) 0.72 0.01
uPAR TR-FIA2
(n=11) 0.89 0.0002
uPAR TR-FIA4
(n=11) 0.73 0.01
Table 5.1. DCE-CT mean-values (2D ROIs) for all the ‘scanned’ cases.
Perfusion Values in the normal liver parenchyma
Perfusion Index
(%)
20.96 [18.59 - 23.32]
Arteriel Flow
(mL/min/100 g)
48.47 [41.86 - 55.07]
Portal flow
(ml/min/100 g)
189.67 [165.10 - 214.24]
Note: Values are given as mean values (2D ROIs), with 95% CIs in brackets.
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